Uveitis intermedia as the initial presentation of a primary lymphoma of the central nervous system.

Intraocular methotrexate Linfoma ocular Linfoma primario del sistema nervioso central Metotrexato intraocular Ocular lymphoma Primary central nervous system lymphoma Uveitis intermediate Uveítis intermedia

Journal

Archivos de la Sociedad Espanola de Oftalmologia
ISSN: 2173-5794
Titre abrégé: Arch Soc Esp Oftalmol (Engl Ed)
Pays: Spain
ID NLM: 101715860

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 06 10 2020
accepted: 15 12 2020
entrez: 6 3 2022
pubmed: 7 3 2022
medline: 9 3 2022
Statut: ppublish

Résumé

Primary central nervous system lymphoma is one of the most infrequent brain tumours, accounting for 3% of primary central nervous system neoplasms. In addition to its low prevalence, clinical presentation is usually nonspecific, leading to diagnostic delay. Intraocular involvement occurs in 15% of cases, and disease onset in this location is even rarer. We present a case of a patient with intermediate uveitis as the first clinical manifestation of this neoplasm.

Identifiants

pubmed: 35248399
pii: S2173-5794(21)00168-7
doi: 10.1016/j.oftale.2020.12.013
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

168-171

Informations de copyright

Copyright © 2021 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

M V Giménez (MV)

Servicio de Neurología, Hospital Italiano de Buenos Aires, Argentina; Servicio de Oftalmología, Hospital Italiano de Buenos Aires, Argentina; Servicio de Hematología, Hospital Italiano de Buenos Aires, Argentina. Electronic address: mauricio.valiere@hospitalitaliano.org.ar.

A Pappolla (A)

Servicio de Neurología, Hospital Italiano de Buenos Aires, Argentina; Servicio de Oftalmología, Hospital Italiano de Buenos Aires, Argentina; Servicio de Hematología, Hospital Italiano de Buenos Aires, Argentina.

L Varela (L)

Servicio de Neurología, Hospital Italiano de Buenos Aires, Argentina; Servicio de Oftalmología, Hospital Italiano de Buenos Aires, Argentina; Servicio de Hematología, Hospital Italiano de Buenos Aires, Argentina.

M Brusztyn (M)

Servicio de Neurología, Hospital Italiano de Buenos Aires, Argentina; Servicio de Anatomía Patológica, Hospital Italiano de Buenos Aires, Argentina; Servicio de Oftalmología, Hospital Italiano de Buenos Aires, Argentina; Servicio de Hematología, Hospital Italiano de Buenos Aires, Argentina.

D Kohan (D)

Servicio de Anatomía Patológica, Hospital Italiano de Buenos Aires, Argentina; Servicio de Oftalmología, Hospital Italiano de Buenos Aires, Argentina; Servicio de Hematología, Hospital Italiano de Buenos Aires, Argentina.

L Patrucco (L)

Servicio de Neurología, Hospital Italiano de Buenos Aires, Argentina; Servicio de Oftalmología, Hospital Italiano de Buenos Aires, Argentina; Servicio de Hematología, Hospital Italiano de Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH